We recently published an article titled Jim Cramer Discusses These 10 Stocks & DeepSeek’s Limitations. In this article, we ...

Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.

Morgan Stanley analyst Dara Mohsenian maintained an Overweight rating and increased the price target from $103 to $111 on ...

Evercore ISI lowered the firm’s price target on Colgate-Palmolive (CL) to $100 from $105 and keeps an Outperform rating on the shares. Shares ...

Colgate-Palmolive is down 4.3% since the beginning of the year, and at $86.70 per share, it is trading 20.3% below its 52-week high of $108.77 from September 2024.

Colgate-Palmolive's adjusted EPS reached $0.91, exceeding analyst expectations of $0.89. Revenue fell slightly short at $4.944 billion compared to the $4.98 billion estimate. The company ...

Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.

NEW YORK, Jan 31 (Reuters) - Colgate Palmolive (CL.N), opens new tab is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company manufactures in Mexico for ...

Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.